Business expansion
Centre-Est; Rhône-Alpes; Rhône
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

125 jobs
Number of planned job creations
Job creation
Announcement Date
19 January 2017
Employment effect (start)
1 January 2017
Foreseen end date
31 December 2017


The pharmaceutical manufacturer Merial has announced the hiring of 125 people in Lyon and its region, and will have a total of 1,750 employees on its Lyon sites this year. Merial was previously part of the French pharmaceutical group Sanofi. It was sold to the German pharmaceutical group Boehringer Ingelheim in early January 2017. Its global headquarters, previously based in Lyon, will be transferred to Ingelheim am Rhein in Germany, but the group highlights that the Lyon site will remain a "key operational centre" for its activities. Following the merger of the German company with Merial, the new company aims to become the world's No. 1 animal health company, with 50,000 employees worldwide. The group has decided about €140 investments in its sites in the Lyon area and to build a new regional headquarter in Gerland near Lyon.


  • 19 January 2017: France 3 Rhône Alpes
  • 20 January 2017: L'usine Nouvelle


Eurofound (2017), Merial, Business expansion in France, factsheet number 89810, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/89810.